ArticleRisk management and healthcare policy2025
Association of the Triglyceride-Glucose Index with Body Composition and Laboratory Parameters in Chronic Kidney Disease Stages 3-5.
Article in Risk management and healthcare policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The triglyceride-glucose index in chronic kidney disease: a narrative review.Frontiers in nutrition · 2026Review
- Albumin: a mediator of the association between serum calcium and triglyceride-glucose index among Chinese individuals with osteoporotic fractures.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the association of the triglyceride-glucose index (TyG index) with body composition and laboratory parameters in individuals with chronic kidney disease (CKD) stage 3-5. Methods: A total of 89 individuals with CKD stages 3-5 were classified into two groups based on glomerular filtration rate (GFR): the CKD stages 3 to 4 group (n = 53) and the CKD stage 5 group (n = 36). Body composition parameters, including body fat mass, lean body mass, skeletal muscle mass, and body mass index, were measured. Laboratory indices, including hemoglobin, albumin, cholesterol, and the TyG index were analyzed. The correlations between the TyG index and these parameters were analyzed using Pearson correlation, and the factors of the TyG index were analyzed using linear regression. Results: (1) Hemoglobin levels, lymphocyte counts, the TyG index, and low-density lipoprotein cholesterol concentrations were higher in patients with CKD stages 3 to 4 compared to those with CKD stage 5. (2) Measures of body composition, including body fat mass, lean body mass, skeletal muscle mass, and BMI were significantly higher in patients with CKD stages 3 to 4 compared to those with CKD stage 5. (3) The TyG index exhibited positive correlations with cholesterol, lymphocyte and monocyte counts, fasting blood glucose, triglycerides, low-density lipoprotein cholesterol, and BMI, while showing a negative correlation with serum creatinine levels. (4) Multivariate linear regression suggested that creatinine, blood glucose, GFR, triglycerides, low-density lipoprotein, and monocyte-lymphocyte ratio may be the influencing factors of TYG index. Conclusion: TYG index was positively correlated with BMI. The TyG index, an indicator of insulin resistance, is closely linked to chronic inflammation, impaired renal function, and alterations in blood glucose and lipid profiles. These findings underscore the potential utility of the TyG index in assessing metabolic and inflammatory changes in CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.